ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

mecobalamin

Also written as “E0302 (mecobalamin)”, “Methylconalamin Injection(WP205)” and “Methylcobalamin Injection(WP205)”.

Its studies are mostly in Amyotrophic Lateral Sclerosis · Dementia · Peripheral Nervous System Diseases, led by 2 companies.

Drug pageMecobalamin: every studyAll 28 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Sep 12, 20058 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Eisaiits history only60 open or runningphase 4since Sep 12, 2005Sep 12, 2005none ahead
Wanbangde Pharmaceutical Group20 open or runningphase 1since Aug 27, 2025Aug 27, 2025none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Wanbangde Pharmaceutical Group only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Aug 27, 2025First study: phase 1 study in Therapeutic Equivalency, HealthyFirst studyNCT07158099 · 14 enrolled · China
  2. Nov 19, 2025Phase 1 study in Therapeutic Equivalency, HealthyNCT07281872 · 20 enrolled · China

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 2 Wanbangde Pharmaceutical Group leads, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07281872Therapeutic Equivalency, Healthy · China1CompletedNov 6, 202520
NCT07158099Therapeutic Equivalency, Healthy · China1CompletedSep 18, 202514

How it is read

Names in the registry

  • “E0302 (mecobalamin)”, 3 entries
  • “Methylconalamin Injection(WP205)”, 1 entry
  • “Methylcobalamin Injection(WP205)”, 1 entry
  • “Methylcobalamin for Injection”, 1 entry
  • “methylcobalamin”, 1 entry

Codes read as this program: WP205, E0302.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.